Identification of secreted proteins that reflect autophagy dynamics within tumor cells

Autophagy

Volumn 11, Issue 1, 2015, Pages 60-74

  Kraya, Adam A ^a,b   Piao, Shengfu ^c   Xu, Xiaowei ^d   Zhang, Gao ^a   Herlyn, Meenhard ^a   Gimotty, Phyllis ^d   Levine, Beth ^e   Amaravadi, Ravi K ^c   Speicher, David W ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autophagy; Biomarker; Cancer; Melanoma; Secretome

Indexed keywords

DICKKOPF 1 PROTEIN; FAMILY SEQUENCE SIMILARITY 3 MEMBER C; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; PROTEIN; UNCLASSIFIED DRUG; ATG7 PROTEIN, HUMAN; CULTURE MEDIUM; SMALL INTERFERING RNA; TUMOR MARKER; TUMOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CARCINOGENESIS; CELL DEATH; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CELLULAR SECRETION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MELANOMA CELL LINE; METASTATIC MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; TUMOR CELL; TUMOR MICROENVIRONMENT; BLOOD; CELL PROLIFERATION; CULTURE MEDIUM; GENE SILENCING; MELANOMA; METABOLISM; METASTASIS; MULTICELLULAR SPHEROID; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; ULTRASTRUCTURE;

AUTOPHAGY; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA; GENE SILENCING; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84923367765     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/15548627.2014.984273     Document Type: Article

References (60)

1. Ma XH, Piao S, Wang D, McAfee QW, Nathanson KL, Lum JJ, Li LZ, Amaravadi RK. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res 2011; 17: 3478-89; PMID:21325076; http://dx.doi.org/10.1158/1078-0432.CCR-10-2372
2. Levine B, Kromer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42; PMID:18191218; http://dx.doi.org/10.1016/j.cell.2007.12.018
3. Amaravadi RK, Lippincott-Schwartz J, Yin YM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17: 654-66; PMID:21325294; http://dx.doi.org/10.1158/1078-0432.CCR-10-2634
4. Rong Y, McPhee CK, Deng S, Huang L, Chen L, Liu M, Tracy K, Baehrecke EH, Yu L, Lenardo MJ. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc Natl Acad Sci USA 2011. 108: 7826-31; PMID: 21518918; http://dx.doi.org/10.1073/pnas.1013800108
5. Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 2012 18: 370-9; PMID:22080440; http://dx.doi.org/10.1158/1078-0432.CCR-11-1282
6. Ganesan AK, Ho H, Bodemann B, Petersen S, Aruri J, Koshy S, Richardson Z, Le L Q, Krasieva T, Roth M G, et al. Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet 2008; 4: e1000298; PMID:19057677; http://dx.doi.org/10.1371/journal.pgen.1000298
7. Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366: 707-714; PMID:22356324; http://dx.doi.org/10.1056/NEJMoa1112302
8. Leone RD, Amaravadi RK. Autophagy: a targetable linchpin of cancer cell metabolism. Trends Endocrinol Metab 2013; 24: 209-17; PMID:23474062; http://dx.doi.org/10.1016/j.tem.2013.01.008
9. Barnard RA, Wittenburg LA, Amaravadi RK, Gustafson DL, Thorburn A, Thamm DH. Phase I and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in dogs with spontaneously occurring lymphoma. Autophagy 2014; 10(8): 1415-1425.
10. Vogl D T, Stadtmauer EA, Heitjan DF, Tan KS, Rangwala R, Piao S, Chang Y C, Scott EC, Paul TM, Nichols CW, et al. Combined autophagy and proteasome inhibition: Phase I trial of hydroxychloroquine with bortezomib in patients with relapsed refractory multiple myeloma. Autophagy 2014; 10(8): 1380-1390; PMID:24991834; http://dx.doi.org/10.4161/auto.29264
11. Mahalingam D, Mita M, Sarantopoulos J, Amaravadi RK, Davis LE, Mita A, Curiel T, Nawrocki ST, Giles FJ, Carew JS. Combined Inhibition of Autophagy and HDAC inhibition: A Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Analysis of Hydroxychloroquine in Combination with the HDAC Inhibitor Vorinostat in Patients with Advanced Solid Tumors. Autophagy 2014; 10(8): 1403-1414; PMID:24991835; http://dx.doi.org/10.4161/auto.29231
12. Rosenfeld MR, Supko JG, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Troxel A, et al. A Phase I/II Trial of Hydroxychloroquine in Conjunction with RadiationTherapy and Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme. Autophagy 2014; 10(8): 1359-1368; PMID: 24991840; http://dx.doi.org/10.4161/auto.28984
13. Rangwala R, Chang YC, Hu J, Algazy K, Evans T, Fecher LA, Schuchter LM, Torigian D, Troxel A, Tan KS, et al. Combined mTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 2014; 10(8): 1391-402.
14. Rangwala R, Leone R, Chang C, Fecher LA, Schuchter LM, Kramer A, Tan KS, Hetjian DF, Rodgers G, Gallagher M, et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 2014; 10(8): 1369-79.
15. Barth S, Glick D, Macleod KF. Autophagy: assays and artifacts. J Pathol 2010; 221: 117-24; PMID:20225337; http://dx.doi.org/10.1002/path.2694
16. Martinet W, De Meyer GRY, Andries L, Herman AG, Kockx MM. In Situ Detection of Starvation-induced Autophagy. J Histochem Cytochem 2006; 54: 85-96; PMID:16148314; http://dx.doi.org/10.1369/jhc.5A6743.2005
17. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL1B. EMBO J 2011; 30: 4701-11; PMID:22068051; http://dx.doi.org/10.1038/emboj.2011.398
18. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, Hong S, Berry LS, Reichelt S, Ferreira M, et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332: 966-70; PMID:21512002; http://dx.doi.org/10.1126/science.1205407
19. DeSelm CJ, Miller BC, Zou W, Beatty WL, van Meel E, Takahata Y, Klumperman J, Tooze S A, Teitelbaum SL, Virgin HW. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell 2011; 21: 966-74; PMID:22055344; http://dx.doi.org/10.1016/j.devcel.2011.08.016
20. Juhasz I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Valyi-Nagy IT, Herlyn M. Growth and Invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 1993; 143: 528-37; PMID:8342600
21. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
22. Roxas Q, Li BA. Significance analysis of microarray for relative quantitation of LC/MS data in proteomics. BMC Bioinformatics 2008; 9: 187-203; PMID:18402702; http://dx.doi.org/10.1186/1471-2105-9-187
23. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2006; 17: 349-56; http://dx.doi.org/10.1093/protein/gzh037
24. Dowling P, Clynes M. Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 2011; 11: 794-804; PMID:21229588; http://dx.doi.org/10.1002/pmic.201000530
25. Bracher A, Cardona AS, Tauber S, Fink AM, Steiner A, Pehamberger H, Niederleithner H, Petzelbauer P, Groger M, Loewe R. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 2013; 133: 230-8; PMID:22951723; http://dx.doi.org/10.1038/jid.2012.272
26. Villiger PM, Geng Y, Lotz M. Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 1993; 91: 1575-81; PMID:8473500; http://dx.doi.org/10.1172/JCI116363
27. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735-41; PMID:18980965; http://dx.doi.org/10.1158/1078-0432.CCR-07-4843
28. Harris J. Autophagy and Cytokines. Cytokine 2011; 56: 140-44; PMID:21889357; http://dx.doi.org/10.1016/j.cyto.2011.08.022
29. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003; 100: 2645-50
30. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011; 68: 3033-46; PMID:21637948; http://dx.doi.org/10.1007/s00018-011-0735-1
31. Egea C, Ries V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109: 4055-63; PMID:17197427; http://dx.doi.org/10.1182/blood-2006-10-051060
32. Kawano Y, Kypta R. Secreted antagonists of the Wnt signaling pathway. J Cell Sci 2003; 116: 2627-2634; PMID:12775774; http://dx.doi.org/10.1242/jcs.00623
33. Gustafson B, Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 2006; 281: 9507-16; PMID:16464856; http://dx.doi.org/10.1074/jbc.M512077200
34. Laffin B, Petrash JM. Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers. Front Pharmacol 2012; 3: 104; PMID:22685431; http://dx.doi.org/10.3389/fphar.2012.00104
35. Ramana KV, Tammali R, Reddy AB, Bhatnagar A, Srivastava SK. Aldose reductase-regulated tumor necrosis factor-alpha production is essential for high glucoseinduced vascular smooth muscle cell growth. Endocrinology 2007; 148: 4371-84; PMID:17584970; http://dx.doi.org/10.1210/en.2007-0512
36. Zhang Z, Huang L, Zhao W, Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 2010; 70: 2379-88; PMID:20215502; http://dx.doi.org/10.1158/0008-5472.CAN-09-4204
37. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M, Beug H. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 2006; 10: 227-39; PMID:16959614; http://dx.doi.org/10.1016/j.ccr.2006.07.020
38. Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, Wilkins AD, Sun Q, Pallauf K, Mac- Duff D, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013; 494: 201-6; PMID:23364696; http://dx.doi.org/10.1038/nature11866
39. Pyo JO, Yoo SM, Ahn HH, Nah J, Hong SH, Kam TI, Jung S, Jung YK. Overexpression of ATG5 in mice activates autophagy and extends lifespan. Nat Commun 2013; 4: 2300; PMID:23939249; http://dx.doi.org/10.1038/ncomms3300
40. Manjithaya R, Subramani S. Role of autophagy in unconventional protein secretion. Autophagy 2010; 6: 650-1; PMID:20473033; http://dx.doi.org/10.4161/auto.6.5.12066
41. Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris D A, Dinarello CA, Fujita M. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 2010; 285: 6477-88; PMID:20038581; http://dx.doi.org/10.1074/jbc.M109.064907
42. Levine B, Mizushima N, Virgin H W. Autophagy in immunity and inflammation. Nature 2011; 469: 323-35; PMID:21248839; http://dx.doi.org/10.1038/nature09782
43. Byrne BG, Dubuisson JF, Joshi AD, Persson JJ, Swanson MS. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. MBio 2013; 4: e00620-12; PMID: 23404401; http://dx.doi.org/10.1128/mBio.00620-12
44. Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012; 13: 343-51; PMID:22430787; http://dx.doi.org/10.1038/ni.2224
45. Singh RK, Varney ML. Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res 1998; 58: 1532-7; PMID:9537260
46. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997; 151: 1105-13; PMID:9327744
47. Salas EM, Garcia-Barchino MJ, Labiano S, Shugay M, Perez-Encinas M, Quinteiro C, Garcia-Delgado M, Vizmanos JL, Novo FJ. LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative Neoplasms. Genes Cancer 2011; 2: 593-6; PMID:21901172; http://dx.doi.org/10.1177/1947601911420139
48. Maruta S, Takiguchi S, Ueyama M, Kataoka Y, Oda Y, Tsuneyoshi M, Iguchi H. A role for leukemia inhibitory factor in melanoma-induced bone metastasis. Clin Exp Metastasis 2009; 26: 133-41; PMID:18953658; http://dx.doi.org/10.1007/s10585-008-9223-x
49. Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van FZijl, Huber H, Csiszar A, Beug H, Mikulits W. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 2009; 28: 638-50; PMID: 19015638; http://dx.doi.org/10.1038/onc.2008.418
50. Yue W, Sun Q, Dacic S, Landreneau RJ, Siegfried JM, Yu J, Zhang L. Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 2007; 29: 84-92; PMID:18048388; http://dx.doi.org/10.1093/carcin/bgm267
51. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H, Huh NH. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 2005; 65: 9617-22; PMID:16266978; http://dx.doi.org/10.1158/0008-5472.CAN-05-0829
52. Yang ZR, Dong WG, Lei XF, Liu M, Liu QS. Overexpression of Dickkopf-3 induces apoptosis through mitochondrial pathway in human colon cancer. World J Gastroenterol 2012; 18: 1590-601; PMID: 22529687; http://dx.doi.org/10.3748/wjg.v18.i14.1590
53. Veeck J, Dahl E. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys Acta 2012; 1825: 18-28; PMID:21982838
54. Untergasser G, Steurer M, Zimmermann M, Hermann M, Kern J, Amberger A, Gastl G, Gunsilius E. The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer 2008; 122: 1539-47; PMID:18033687; http://dx.doi.org/10.1002/ijc.23255
55. Beer LA, Tang HY, Sriswasdi S, Barnhart KT, Speicher DW. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J Proteome Res 2011; 10: 1126-38; PMID:21142075; http://dx.doi.org/10.1021/pr1008866
56. Pesciotta E N, Sriswasdi S, Tang HY, Mason PJ, Bessler M, Speicher DW. A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders. J Proteomics 2012; 76: 194-202; PMID:22954596; http://dx.doi.org/10.1016/j.jprot.2012.08.010
57. auf dem Keller U, Prudova A, Gioia M, Butler GS, Overall CM. A statistics-based platform for quantitative N-terminome analysis and identification of protease cleavage products. Mol Cell Proteomics 2010; 9: 912-27; PMID:20305283; http://dx.doi.org/10.1074/mcp.M000032-MCP201
58. Baitaluk M, Sedova M, Ray A, Gupta A. Biological-Networks: visualization and analysis tool for systems biology. Nucleic Acids Res 2006; 34: 466-71; http://dx.doi.org/10.1093/nar/gkl308
59. Baitaluk M, Kozhenkov S, Dubinina Y, Ponomarenko J. IntegromeDB: an integrated system and biological search engine. BMC Genomics 2012; 13: 35; PMID:22260095; http://dx.doi.org/10.1186/1471-2164-13-35
60. Amaravadi RK, Schuchter LM, McDermott DF, Kramer A, Giles L, Gramlich K, Carberry M, Troxel AB, Letrero R, Nathanson KL, et al. Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases. Clin Cancer Res 2009; 15: 7711-7718; PMID:19996224; http://dx.doi.org/10.1158/1078-0432.CCR-09-2074